In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 07 September 2016 |
| Author/s | |
| Publication date | September 8, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |